Issuer positions
1
Reporting Owner Activity for Daniel W. Muehl
Form 3/4/5 issuer positions and transaction evidence for this reporting owner.
Largest position
Clovis Oncology, Inc.
Disclosed value
$103K
Recent activity
Available
- Forms 3/4/5 ownership summary
-
Estimated reporting-owner value
$103,037
Estimated from parsed Forms 3/4/5 when the filing discloses enough holding data.
Issuer relationships
1
Distinct issuers tied to this reporting owner in parsed SEC filings.
Largest issuer position
Clovis Oncology, Inc.
$103K estimated from parsed reporting-owner filings.
Latest owner filing
03 Nov 2022
Most recent owner-level filing date in the parsed SEC record.
How to read Forms 3/4/5 positions
- Reported values are estimates from parsed SEC Forms 3/4/5 when the filing includes enough price and share data.
- Verify the source filing before treating any owner position as current.
- Location
- North Billerca, MA
- SEC signature
- /s/ Daniel Muehl
- Source evidence
- Open source filing history
SEC ownership signals
1 fact
Identity
1 fact
SEC filing record
1 fact
SEC evidence
1 fact
Follow Filing Activity
Follow Daniel W. Muehl and return when a new Insider Trading filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean. If you create an account from here, we will bring you back after verification.
Reported issuer positions for Daniel W. Muehl
CLVS
Forms 3/4/5
Clovis Oncology, Inc.
- Relationship
- Executive Vice President and Chief Financial Officer
- Holdings value
- $103,037
- Past year net change
- Change %
- Report period
- 01 Nov 2022
Recent insider transactions for Daniel W. Muehl
| Sym | Company | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.